ArticleJournal of the Royal Society of Medicine2024

The difference in all-cause mortality between COVID-19 patients treated with standard of care plus placebo and those treated with standard of care alone: a network meta-analysis of randomised controlled trials of immunomodulatory kinase inhibitors.

Ping-Tao Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.